PATENT CLAIM ANALYSIS

Application Number: 16016540
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
Provided are compositions and methods that involve recombinant Newcastle disease viruses (rNDVs), and recombinant vectors that encode them. The rNDVs comprise and/or encode a combination of at least two proteins that are hemagglutinin (HA), neuraminidase (NA) protein, matrix 1 protein (M1), or nonstructural 1 protein (NS1). The HA, NA, protein, M1, and nonstructural 1 protein (NS1) are from Avian Influenza virus (AIV). Method are provided and involve administering an immunologically effective amount rNDV to avian animals to stimulate a protective immune response the rNDV administration constitutes a first (prime) immunization, which can be followed by a second (boost) administration with an avirulent NVD that may include/encode an AIV HA. The avian animals can survive challenges from pathogenic and highly pathogenic NVD and AIV.

Claim (Index 11):
The method of  claim 10 , wherein the avirulent NVD further comprises and/or encodes AIV HA.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.89024
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15434353', '12753597', '14268302', '11633130', '15059927']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7668731943298139
- 35 USC 102 Novelty (BERT): 0.5534259286364944
- Combined Prediction Score: 0.745528467760482
- Mean Citation Score: 427.24732000000006
- Max Citation Score: 451.1641
- Similarity Product: 298.92774381636383

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test